← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 30, 2018Last known activity
Nov 30, 2018
Acquired by Coda Biotherapeutics on Feb 5, 2020
Timeline
2010s
- Jun 1, 2015
Attenua, Inc.— Founded
2020s
- Feb 5, 2020
Coda Biotherapeutics— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03622216Study directorPhase 2Nov 30, 2018
- NCT03622216Lead sponsorPhase 2Nov 30, 2018
Details
- Founded
- Mountain View, CA, US Jun 1, 2015
- Last known activity
- Nov 30, 2018